Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
Leukemia|November 26, 2016
Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cellsF Yan, N Shen, J X Pang, et al.Leukemia|November 11, 2005
Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemiaD Behl, L F Porrata, S N Markovic, et al.British Journal of Haematology|April 8, 1998
Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantationA Palmas, A Tefferi, J L Myers, et al.Bone Marrow Transplantation|November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateM A Gertz, M Q Lacy, A Dispenzieri, et al.Bone Marrow Transplantation|December 2, 2000
Effect of complete response on outcome following autologous stem cell transplantation for myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.Cytotherapy|June 24, 2006
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CMLM R Litzow, A B Dietz, P A Bulur, et al.Bone Marrow Transplantation|March 9, 2010
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignanciesS G Holtan, W J Hogan, M A Elliott, et al.Bone Marrow Transplantation|May 11, 2004
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapyS Kumar, M Q Lacy, A Dispenzieri, et al.Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.Pageof 9